Skip to main content
letter
. 2018 Sep;103(9):e392–e394. doi: 10.3324/haematol.2017.185751

Figure 1.

Figure 1.

Survival estimates of 376 patients with post polycythemia vera and post essential thrombocythemia myelofibrosis according to karyotype (normal versus abnormal). Median survival was 10.1 years (95% CI: 8.1-NR) in patients with NK and 6.1 years (95% CI 4.8-NR) in those with AK (P=0.012). Survival curves not overlapping the shaded region are significantly different at the 95% level.